Individualized radial extracorporeal shock wave therapy (rESWT) for

symptomatic calcific shoulder tendinopathy: a retrospective clinical study

​

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5718020/

​

 

“One-year success rate was estimated at 92% and 1-year recurrence rate was 7%.”

 

​

​

 

The effectiveness of extracorporeal shockwave therapy for frozen

shoulder in patients with diabetes: randomized control trial

​

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642889/

​

“The Shockwave group benefited from significantly increased pain reduction, reduced number of therapy sessions and thus the costs of treatment compared to the Ultrasound group.” 

 

​

 

Effectiveness of radial extracorporeal shock-wave therapy versus

ultrasound-guided low-dose intra-articular steroid injection in improving

shoulder pain, function, and range of motion in diabetic patients with

shoulder adhesive capsulitis

​

https://pubmed.ncbi.nlm.nih.gov/32553435/

 

​

“Both groups demonstrated a significant reduction in pain severity, as well as improvement in ROM. However, significantly greater function and shoulder pain reduction were found in the rESWT group vs. the steroid group. Similar improvement in shoulder ROM was observed in both groups.”

 

​

​

​

Effect of extracorporeal shock-wave therapy for treating patients with

chronic rotator cuff tendonitis

​

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585514/

 

​

“The results of all outcome measurements show [shockwave therapy] significantly decreased the intensity of shoulder pain associated with chronic rotator cuff tendonitis, and increased shoulder function at both 4 and 8 weeks after the treatment.”

​

​

​

​

Extracorporeal shockwaves therapy versus hyaluronic acid injection

for the treatment of painful non-calcific rotator cuff

tendinopathies: preliminary results

​

https://pubmed.ncbi.nlm.nih.gov/27070534/

​

​

“low molecular weight hyaluronic acid and shockwave therapy are both effective and safe in patients suffering from non-calcific rotator cuff tendinopathy until 3 months of follow-up.”